Unknown

Dataset Information

GOLPH3: a novel biomarker that correlates with poor survival and resistance to chemotherapy in breast cancer.


ABSTRACT: The association between Golgi phosphoprotein 3 (GOLPH3) and clinical pathological characteristics, as well as the clinical outcomes of both neoadjuvant and adjuvant chemotherapies in breast cancer, remain largely unknown. In this study, we investigated the biological role and clinical significance of GOLPH3 in breast cancer. We found that GOLPH3 expression in tumor tissue was higher than that in adjacent noncancerous tissue (ANT) and fibroadenoma. GOLPH3 silencing reduced the migration, invasion, and proliferation of breast cancer cells and promoted apoptosis of the cells. Importantly, patients with high GOLPH3 expression had worse disease-free survival (DFS) and overall survival (OS), and GOLPH3 expression was correlated with clinical pathological characteristics such as molecular subtype

SUBMITTER: Tang S 

PROVIDER: S-EPMC5739628 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature